BioSpace News Archive

Press Releases

Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO’s Heart Technology Presented at ISHLT in Toronto

April 23, 2026
·
3 min read
Press Releases

George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous intracerebral hemorrhage

April 23, 2026
·
12 min read
Press Releases

AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER

April 23, 2026
·
9 min read
Press Releases

Altimmune Announces Proposed Underwritten Public Offering of Securities

April 23, 2026
·
4 min read
Press Releases

Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - April 22, 2026

April 23, 2026
·
2 min read
Press Releases

Vanda Pharmaceuticals Appoints Dr. Charles Duncan to its Board of Directors

April 23, 2026
·
5 min read
Press Releases

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

April 23, 2026
·
3 min read
Press Releases

Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)

April 23, 2026
·
27 min read
Press Releases

Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria

April 23, 2026
·
18 min read
Press Releases

Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day

April 23, 2026
·
9 min read